Medical device and digital healthcare company Alimetry has received US Food and Drug Administration (FDA) clearance for its non-invasive medical device, Gastric Alimetry, which is aimed at helping diagnose gastric disorders.
CEO Greg O’Grady, professor of surgery and a co-founder at the company,
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
